Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The initiation and prevention of multiple sclerosis.
Individual variation of human sphingosine 1-phosphate receptor 1 coding sequence leads to heterogeneity in receptor function and drug interactions.
Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open-label study.
Rectus abdominis muscle endometriotic mass in a woman affected by multiple sclerosis.
Novartis gains FDA approval for Gilenya(TM), a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Iron Level and Myelin Content in the Ventral Striatum Predict Memory Performance in the Aging Brain.
Innovation at RUSH
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.
Phase 2 results of the RADIANCE trial: a randomized, double-blind, placebo-controlled trial of oral RPC1063 in relapsing multiple sclerosis
Management of children with multiple sclerosis.
Psychotherapeutic and psychosocial interventions for managing stress in multiple sclerosis: the contribution of mindfulness-based interventions.
Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation.
Immune reconstitution inflammatory syndrome in a patient treated with natalizumab presenting progressive multifocal leukoencephalopathy.
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.
Review of MR elastography applications and recent developments.
Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
MiR-126: a novel route for natalizumab action?
mfERG_LAB: Software for processing multifocal electroretinography signals.
New Disease-Modifying Therapies and New Challenges for MS.
Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
The role of growth factors as a therapeutic approach to demyelinating disease.
Is it time for a new global classification of multiple sclerosis?
Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.
Epidural blood patch in a patient with multiple sclerosis: is it safe?

Pages